'Nolitsin'. Ntuziaka maka ojiji, contraindications

The nkwadebe maka ikwu adakarị na pharmacological otu antibacterial fluoroquinolone, mkpụrụ ọgwụ "nolitsin" ntekwasa, nwere oroma agba, biconcave, gburugburu, na a notch na otu akụkụ.

Norfloxacin - ifịk umi - na mbadamba bụ 400 mg. Enyemaka e dere ihe na-esonụ:

- talc;

- sodium starch glycolate;

- titanium dioxide;

- povidone;

- hydroxypropyl methylcellulose;

- propylene glycol;

- magnesium stearate.

Antimicrobial "nolitsin" ntuziaka nke nwere ihe ọmụma banyere ihe ndị na-egosi, nwere obosara akporo. A na-agụnye a dịgasị iche iche nke na-efe efe mkpali oria, nke na-kpatara microorganisms chebaara ọgwụ. Ya bụ ndị a na-efe efe:

- na kenwe;

- urinary tract;

- digestive tract;

- gonococcal;

- njem afọ ọsịsa. The ọgwụ na-kwukwara ka a mgbochi ụfọdụ megide syphilis.

Practice egosi elu ọrụ ọgwụ "nolitsin", ntụziaka na-akpọ ndị dị otú ahụ nje umu (gram) dị ka Salmonella, Escherichia coli, Proteus, Morganella morgani, Shigella, Klebsiella spp, Serratia marcescens, Enterobacter, Haemophilus influenzae, Providencia, Yersinia enterocolitica, pseudomonas aeruginosa . Ọzọkwa, gram-mma bacteria Staphylococcus spp na microorganisms - nkwekọrịta nke beta-lactamase. Streptococci na anaerobic bacteria na-eguzogide ọgwụ na ọgwụ "nolitsin" ntụziaka na-egosi a ala ogo ọrụ megide Enterococcus, Acinetobacter.

The ọgwụgwọ bụ n'ozuzu ruo izu 2, ọ mkpa ịgbatị n'elu a ogologo oge.

Absorption nke ọgwụ na-adị ngwa ngwa, ma ọ bụghị kpamkpam, naanị ruo 40%, a kacha abụọ awa a na-enweta ndị kasị ukwuu ịta, imesị 67% nke nọ n'ọrụ umi penetrates ahụ anụ ahụ. Na gallbladder, imeju, opi mgbailu, prostate na akụrụ hụrụ ịta "nolitsin" karịa plasma.

Egosipụta ọgwụ mgbe a kacha nke 6.5 awa 80% site na akụrụ na mbụ ha, ụdị, na site na ndị fọdụrụ akụkụ nke eriri afọ bụ mmepụta. Dị ka awa 12 na-adịgide adịgide antimicrobial mmetụta.

Ọ bụghị ihe niile ndị ọrịa kwesịrị ekwesị na nkà mmụta ọgwụ "nolitsin" contraindications metụtara ụmụ nwaanyị dị ime ma ọ bụrụ na afọ nke onye ọrịa n'okpuru afọ 18, lactating inyom, ọrịa na hypersensitivity ka norfloxacin.

Akwụkwụ na-adọ ndị ọrịa na oke-elekọta kwesịrị iwere "nolitsin" ntuziaka adọkwa aka ná ntị banyere ihe ndị na-egosi maka ọrịa na gbasara akụrụ insufficiency, na cramps. Ọrịa e kwesịrị ọtụtụ oke mmiri ga na-achịkwa ọbara clotting n'oge usoro ịwa ahụ. Nke a bụ n'ihi na-abawanye na prothrombin index.

Ekwesịghị emegbu site anyanwụ n'oge ọgwụgwọ "nolitsin" ma ọ bụrụ na na akwara, ihe mgbu, ọgwụ a ga-kwụsịrị mgbe a mgbaàmà nke tenosynovitis. Ma ọ bụ ka anyị kwesịrị ime ihe ike nkịtị nchegbu, ma n'oge ọgwụgwọ na ozugbo n'elu ya ẹkụre. Ọ bụrụ na ọgwụgwọ a rụrụ na njikọ na "cyclosporin" na "theophylline", na-achọ mgbe nile na nlekota nke ha ọdịnaya n'ime ọbara plasma.

Ma ngwaọrụ, dị ka ígwè Mmeju, sucralfate, zinc, antacids, mgbe na-ewere ha kwesịrị na rụrụ mgbe 2 awa mgbe "nolitsin". Mbelata adsorption nke ọgwụ na-eme ara ehi ngwaahịa na yogot na kwesịrị iwere dị ka ihe oriri a awa ole na ole ma n'ihu ma ọ bụ mgbe ingestion.

Ị kwesịrị ị na-ekenye ya ụmụ ha, ndị nọ n'oge uto, n'ihi na nkà mmụta ọgwụ na-n'ụzọ zuru ezu na-amụ ya na mmetụta na-eto eto na organism na ọ bụ omume ya na-ezighị ezi mmetụta na articular cartilage.

Ekwe omume mgbe ụfọdụ ovadozu "nolitsin" mgbaàmà ndị na-esonụ: vomiting, ọgbụgbọ, afọ ọsịsa, na ihe siri ike mgbe, na o kwere omume dizziness, ụfụ na mgbagwoju anya. Ọgwụgwọ-agụnye symptomatic ọgwụ, gastric lavage na zuru ezu mmanya.